Colorectal cancer treatment: Is Bevacizumab the best option?
@article{TGC965,
author = {Luca Bagnasco and Daniela Piras},
title = {Colorectal cancer treatment: Is Bevacizumab the best option?},
journal = {Translational Gastrointestinal Cancer},
volume = {1},
number = {3},
year = {2012},
keywords = {},
abstract = {Colorectal cancer (CRC) is the third most common neoplastic disease worldwide and the second leading cause of cancer death in the western world (1).},
url = {https://tgc.amegroups.com/article/view/965}
}